Definitive Healthcare Corp. (NASDAQ:DH) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET

Company Participants

David Samuels - General Counsel & Chief Legal Officer

Jason Krantz - Founder and CEO

Robert Musslewhite - President

Richard Booth - Chief Financial Officer

Conference Call Participants

Craig Hettenbach - Morgan Stanley

David Hynes - Canaccord Genuity

Jonathan Yong - Credit Suisse

David Grossman - Stifel

Operator

Greetings, and welcome to Definitive Healthcare First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, David Samuels, General Counsel. Thank you, and over to you.

David Samuels

Good afternoon, and thank you for joining us today to review Definitive Healthcare's First Quarter 2022 Financial Results. During the call today are Jason Krantz, Definitive Healthcare's Founder and CEO; Robert Musslewhite, Definitive Healthcare's President; and Rick Booth, Definitive Healthcare's Chief Financial Officer.

During this call, we will make forward-looking statements, including, but not limited to, statements relating to our markets and future growth opportunities, the benefits of our health care commercial intelligence solutions, our competitive position, customer behaviors, our financial guidance, our planned investments and the anticipated impact from the COVID-19 pandemic on our business and results of operations as well as on our clients, the health care industry generally and the macroeconomic environment.

Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section of our filings with the SEC. Actual results may differ materially from forward-looking statements.

The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statements included in the earnings release that we just posted to the Investor Relations portion of our website.

Additionally, we will discuss non-GAAP financial performance measures on this conference call. References on this call to profitability are on an adjusted EBITDA basis. Please refer to the tables in our earnings release on the Investor Relations portion of our website for a reconciliation of these measures to the most directly comparable GAAP financial measures.

With that, I'd like to turn the call over to Jason.

Jason Krantz

Thanks, David. I would like to thank all of you for joining us this afternoon to discuss Definitive Healthcare's first quarter results.